Skip to content

Evaluation of the Anti-aging Efficacy of Four Skin Health Products

Evaluation of the Anti-aging Efficacy of Four Cosmetic Products

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05473832
Enrollment
144
Registered
2022-07-26
Start date
2022-07-13
Completion date
2022-10-17
Last updated
2023-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anti-Aging, Skin Aging

Brief summary

The purpose of this study is to assess the anti-wrinkle and anti-aging efficacy of four different cosmetic products compared to an untreated control (split-face study design)

Interventions

OTHERDay Cream cosmetic product compared to untreated side

Applied once daily in the morning

OTHERNight cream cosmetic product compared to untreated side

Applied once daily in the evening

OTHEREye cream cosmetic product compared to untreated side

Applied twice daily in the morning and in the evening around the eye area

OTHERSerum cosmetic product compared to untreated side

Applied twice daily in the morning and in the evening

Sponsors

proDERM GmbH
CollaboratorINDUSTRY
Amazentis SA
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Written Informed Consent to participate in the study * Willingness to actively participate in the study and to come to the scheduled visits * Female and male * From 40 to 65 years of age * BMI \< 30 kg/m2 * Healthy skin in the test areas * Uniform skin color and no erythema or dark pigmentation in the test area * Visible wrinkle in the face (grade 3 to 6 according to proderm scale) see Appendix 2 * Ethnicity: at least one Black, Asian and Hispanic subject per study group

Exclusion criteria

* Female subjects: Pregnancy or lactation * Drug addicts, alcoholics * AIDS, HIV-positive or infectious hepatitis * Conditions which exclude a participation or might influence the test reaction/evaluation * Participation or being in the waiting period after participation in cosmetic and/or pharmaceutical studies pertaining to the test area * Active skin disease at the test area * Documented allergies to face/eye care products * Diabetes mellitus * Cancer not being diagnosed as cured and requiring chemotherapy, irradiation and/or hormonal treatment within the last 2 years One of the following illnesses with reduced physical capability/fitness: asthma (symptom-free allergic asthma is not an exclusion criterion), hypertension (if not adjusted with medication), cardiovascular diseases * Epilepsy * Wounds, moles, tattoos, scars, irritated skin, excessive hair growth, freckles, etc. at the test area that could influence the investigation * Sun-tanned skin (important for the subgroup of subjects planned for Raman measurements) * Regular use of tanning beds * Any topical medication at the test area within the last 7 days prior to the start of the study * Systemic therapy with immuno-suppressive drugs (e.g. corticosteroids) and/or antihistamines (e.g. antiallergics) and/or within the last 7 days prior to the start of the study * Past cosmetic surgery procedure in the test area (e.g. laser, facelift) * Cosmetic surgery procedure in the test area, e.g. IPL (Intensed Pulsed Light), botox, chemical peel, dermabrasion within the last 2 years prior to the start of the study and/or throughout the entire course of the study * Medical treatment for wrinkle reduction (e.g. peeling with vitamin A or fruit acids) on the face within the last 2 weeks prior to the start of the study

Design outcomes

Primary

MeasureTime frame
Anti-wrinkle efficacy will be assessed in the periorbital regions wrinkles using DermaTOP. Parameters measured: Rz and Ra, representing mainly the rough structure (Rz) or the finer skin structure (Ra).8-weeks

Secondary

MeasureTime frame
Change from baseline in ceramides by Raman Spectroscopy [a.u.] on a subgroup of n=12 subjects per test product group after 2, 4 and 8 weeks8-weeks
Change from baseline in skin firmness by Cutometer [mm] after 2, 4 and 8 weeks8-weeks
Change from baseline in skin elasticity by Cutometer after 2, 4 and 8 weeks8-weeks
Change from baseline in skin hydration (assessed on skin capacitance by Corneometer [a.u.]) after 2, 4 and 8 weeks8-weeks
Change from baseline in skin barrier function (assessed on transepidermal waterloss by Tewameter [g/(m²h)]) after 2, 4, 8-weeks8-weeks
Change in Image grading (Photodocumentation via USR-Clip) for skin radiance (3 trained graders will rank each pair of images in a blinded fashion) after 2, 4 and 8 weeks8-weeks
Change in wrinkle scores (Photodocumentation via USR-Clip) for anti-wrinkle efficacy (3 trained graders will rank each pair of images at the area of the crow feet's in a blinded manner)8-weeks
Subjective Evaluation of product traits assessed via questionnaire after 2, 4 and 8 weeks8-weeks

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026